Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
NCT ID: NCT06760650
Last Updated: 2025-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
35 participants
INTERVENTIONAL
2025-01-07
2025-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring Renal Blood Flow With Contrast Enhanced Ultrasound During Coronary Angiogram
NCT01544036
Normoalbuminuric Chronic Kidney Disease in Type 2 Diabetes
NCT04411342
Risk Factors for Acute Kidney Injury in Diabetic Patients
NCT05147818
Prognostic Imaging Biomarkers for Diabetic Kidney Disease
NCT03716401
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
NCT06347029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluorescein angiography
Assessing serum creatinine before and after fluorescein angiography
Fluorescein angiography
Fluorescein angiography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluorescein angiography
Fluorescein angiography
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who are allergic to fluorescein
* Patients who are on dialysis
* Patients who had fever, vomiting, diarrhea or any dehydration 48 hours before the intervention
* Patients who had a treatment modification one week before the intervention
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint-Joseph University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mabel Aoun
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mabel AOUN, M.D., M.P.H.
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Saint Joseph University of Beirut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Saint Joseph University of Beirut
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tfem-2025-79
Identifier Type: OTHER
Identifier Source: secondary_id
CEHDF 2587
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.